Actionable news
All posts from Actionable news
Actionable news in ISIS: Isis Pharmaceuticals, Inc.,

ISIS Pharmaceuticals (ISIS) In A Perilous Reversal

Trade-Ideas LLC identified ISIS Pharmaceuticals ( ISIS) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified ISIS Pharmaceuticals as such a stock due to the following factors:

  • ISIS has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $91.5 million.
  • ISIS has traded 70,234 shares today.
  • ISIS is down 3.4% today.
  • ISIS was up 11.3% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in ISIS with the Ticky from Trade-Ideas. See the FREE profile for ISIS NOW at Trade-Ideas More details on ISIS: Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. ISIS has a PE ratio of 245. Currently there are 2 analysts that rate ISIS Pharmaceuticals a buy, 1 analyst rates it a sell, and 5 rate it a hold. The average volume for ISIS Pharmaceuticals has been 1.8 million shares per day over the past 30 days. ISIS has a market cap of $5.6 billion and is part of the health care sector and drugs...